[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022. >《减肥、谁也不想胖+》...
[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022.
[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022.
[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022. 丁香园是面向医疗从业者的专业平台,以「助力中国医生」为己任。下载「丁香园 ...
[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022. 丁香园是面向医疗从业者的专业平台,以「助力中国医生」为己任。下载「丁香园...
值得关注的是,国产抗新冠药物先诺特韦/利托那韦 Ⅱ/Ⅲ 期临床研究于北京时间 2024 年 1 月 18 日在线发表于国际顶级医学期刊The New England Journal of Medicine(NEJM,2022 年 IF=158.5)[6],使该药成为目前首个拥有完整证据链的国产 3CL 抗新冠药物。
[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022. 丁香园...
[12] Domenica M. Rubino et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial. JAMA,January 11, 2022. 传播优...